Literature DB >> 12242309

The neuron-specific Rai (ShcC) adaptor protein inhibits apoptosis by coupling Ret to the phosphatidylinositol 3-kinase/Akt signaling pathway.

Giuliana Pelicci1, Flavia Troglio, Alessandra Bodini, Rosa Marina Melillo, Valentina Pettirossi, Laura Coda, Antonio De Giuseppe, Massimo Santoro, Pier Giuseppe Pelicci.   

Abstract

Rai is a recently identified member of the family of Shc-like proteins, which are cytoplasmic signal transducers characterized by the unique PTB-CH1-SH2 modular organization. Rai expression is restricted to neuronal cells and regulates in vivo the number of postmitotic sympathetic neurons. We report here that Rai is not a common substrate of receptor tyrosine kinases under physiological conditions and that among the analyzed receptors (Ret, epidermal growth factor receptor, and TrkA) it is activated specifically by Ret. Overexpression of Rai in neuronal cell lines promoted survival by reducing apoptosis both under conditions of limited availability of the Ret ligand glial cell line-derived neurotrophic factor (GDNF) and in the absence of Ret activation. Overexpressed Rai resulted in the potentiation of the Ret-dependent activation of phosphatidylinositol 3-kinase (PI3K) and Akt. Notably, increased Akt phosphorylation and PI3K activity were also found under basal conditions, e.g., in serum-starved neuronal cells. Phosphorylated and hypophosphorylated Rai proteins form a constitutive complex with the p85 subunit of PI3K: upon Ret triggering, the Rai-PI3K complex is recruited to the tyrosine-phosphorylated Ret receptor through the binding of the Rai PTB domain to tyrosine 1062 of Ret. In neurons treated with low concentrations of GDNF, the prosurvival effect of Rai depends on Rai phosphorylation and Ret activation. In the absence of Ret activation, the prosurvival effect of Rai is, instead, phosphorylation independent. Finally, we showed that overexpression of Rai, at variance with Shc, had no effects on the early peak of mitogen-activated protein kinase (MAPK) activation, whereas it increased its activation at later time points. Phosphorylated Rai, however, was not found in complexes with Grb2. We propose that Rai potentiates the MAPK and PI3K signaling pathways and regulates Ret-dependent and -independent survival signals.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12242309      PMCID: PMC139827          DOI: 10.1128/MCB.22.20.7351-7363.2002

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  41 in total

Review 1.  Signalling through phosphoinositide 3-kinases: the lipids take centre stage.

Authors:  S J Leevers; B Vanhaesebroeck; M D Waterfield
Journal:  Curr Opin Cell Biol       Date:  1999-04       Impact factor: 8.382

2.  Opposite effects of the p52shc/p46shc and p66shc splicing isoforms on the EGF receptor-MAP kinase-fos signalling pathway.

Authors:  E Migliaccio; S Mele; A E Salcini; G Pelicci; K M Lai; G Superti-Furga; T Pawson; P P Di Fiore; L Lanfrancone; P G Pelicci
Journal:  EMBO J       Date:  1997-02-17       Impact factor: 11.598

3.  Phosphatidylinositol 3-kinase and Akt protein kinase are necessary and sufficient for the survival of nerve growth factor-dependent sympathetic neurons.

Authors:  R J Crowder; R S Freeman
Journal:  J Neurosci       Date:  1998-04-15       Impact factor: 6.167

4.  High-efficiency gene transfer and selection of human hematopoietic progenitor cells with a hybrid EBV/retroviral vector expressing the green fluorescence protein.

Authors:  F Grignani; T Kinsella; A Mencarelli; M Valtieri; D Riganelli; F Grignani; L Lanfrancone; C Peschle; G P Nolan; P G Pelicci
Journal:  Cancer Res       Date:  1998-01-01       Impact factor: 12.701

5.  Role of phosphoinositide 3-kinase in activation of ras and mitogen-activated protein kinase by epidermal growth factor.

Authors:  S Wennström; J Downward
Journal:  Mol Cell Biol       Date:  1999-06       Impact factor: 4.272

6.  Ret-dependent and -independent mechanisms of glial cell line-derived neurotrophic factor signaling in neuronal cells.

Authors:  M Trupp; R Scott; S R Whittemore; C F Ibáñez
Journal:  J Biol Chem       Date:  1999-07-23       Impact factor: 5.157

7.  Two distinct mutations of the RET receptor causing Hirschsprung's disease impair the binding of signalling effectors to a multifunctional docking site.

Authors:  O Geneste; C Bidaud; G De Vita; R M Hofstra; S Tartare-Deckert; C H Buys; G M Lenoir; M Santoro; M Billaud
Journal:  Hum Mol Genet       Date:  1999-10       Impact factor: 6.150

8.  Inhibition of phosphatidylinositol 3-kinase activity blocks cellular differentiation mediated by glial cell line-derived neurotrophic factor in dopaminergic neurons.

Authors:  K Pong; R Y Xu; W F Baron; J C Louis; K D Beck
Journal:  J Neurochem       Date:  1998-11       Impact factor: 5.372

9.  Differential regulation of SHC proteins by nerve growth factor in sensory neurons and PC12 cells.

Authors:  P Ganju; J P O'Bryan; C Der; J Winter; I F James
Journal:  Eur J Neurosci       Date:  1998-06       Impact factor: 3.386

Review 10.  Emerging roles for SH2/PTB-containing Shc adaptor proteins in the developing mammalian brain.

Authors:  E Cattaneo; P G Pelicci
Journal:  Trends Neurosci       Date:  1998-11       Impact factor: 13.837

View more
  25 in total

1.  Signaling adaptor ShcD suppresses extracellular signal-regulated kinase (Erk) phosphorylation distal to the Ret and Trk neurotrophic receptors.

Authors:  Melanie K B Wills; Ava Keyvani Chahi; Hayley R Lau; Manali Tilak; Brianna D Guild; Laura A New; Peihua Lu; Kévin Jacquet; Susan O Meakin; Nicolas Bisson; Nina Jones
Journal:  J Biol Chem       Date:  2017-02-17       Impact factor: 5.157

Review 2.  Multiple endocrine neoplasia syndromes, children, Hirschsprung's disease and RET.

Authors:  S W Moore; M G Zaahl
Journal:  Pediatr Surg Int       Date:  2008-03-26       Impact factor: 1.827

3.  Cell density modulates SHC3 expression and survival of human glioblastoma cells through Fak activation.

Authors:  Alberto Azzalin; Elena Moretti; Eloisa Arbustini; Lorenzo Magrassi
Journal:  J Neurooncol       Date:  2014-07-26       Impact factor: 4.130

4.  Manganese-Mediated Decrease in Levels of c-RET and Tyrosine Hydroxylase Expression In Vitro.

Authors:  Mayuko Y Kumasaka; Ichiro Yajima; Nobutaka Ohgami; Hiromasa Ninomiya; Machiko Iida; Xiang Li; Reina Oshino; Hiroko Tanihata; Masafumi Yoshinaga; Masashi Kato
Journal:  Neurotox Res       Date:  2017-07-20       Impact factor: 3.911

Review 5.  A Link Between Alzheimer's and Type II Diabetes Mellitus? Ca+2 -Mediated Signal Control and Protein Localization.

Authors:  Yuko Tsutsui; Franklin A Hays
Journal:  Bioessays       Date:  2018-04-25       Impact factor: 4.345

6.  An integrative understanding of comparative cognition: lessons from human brain evolution.

Authors:  Yuxiang Liu; Genevieve Konopka
Journal:  Integr Comp Biol       Date:  2020-10-01       Impact factor: 3.326

7.  Biological role of anaplastic lymphoma kinase in neuroblastoma.

Authors:  Yuko Osajima-Hakomori; Izumi Miyake; Miki Ohira; Akira Nakagawara; Atsuko Nakagawa; Ryuichi Sakai
Journal:  Am J Pathol       Date:  2005-07       Impact factor: 4.307

8.  The Rai (Shc C) adaptor protein regulates the neuronal stress response and protects against cerebral ischemia.

Authors:  Flavia Troglio; Cinara Echart; Alberto Gobbi; Tony Pawson; Pier Giuseppe Pelicci; Maria Grazia De Simoni; Giuliana Pelicci
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-19       Impact factor: 11.205

9.  Elevated gene expression levels distinguish human from non-human primate brains.

Authors:  Mario Cáceres; Joel Lachuer; Matthew A Zapala; John C Redmond; Lili Kudo; Daniel H Geschwind; David J Lockhart; Todd M Preuss; Carrolee Barlow
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-13       Impact factor: 11.205

10.  Analysis of a Shc family adaptor protein, ShcD/Shc4, that associates with muscle-specific kinase.

Authors:  Nina Jones; W Rod Hardy; Matthew B Friese; Claus Jorgensen; Matthew J Smith; Neil M Woody; Steven J Burden; Tony Pawson
Journal:  Mol Cell Biol       Date:  2007-04-23       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.